Lord, Abbett & Co’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,197,182
| Closed | -$23.8M | – | 574 |
|
|
2023
Q2 | $23.8M | Buy |
1,197,182
+41,844
| +4% | +$831K | 0.08% | 313 |
|
|
2023
Q1 | $19.8M | Buy |
1,155,338
+619,750
| +116% | +$10.6M | 0.07% | 350 |
|
|
2022
Q4 | $10.5M | Buy |
535,588
+639
| +0.1% | +$12.5K | 0.04% | 420 |
|
|
2022
Q3 | $8.54M | Buy |
534,949
+271,018
| +103% | +$4.33M | 0.03% | 421 |
|
|
2022
Q2 | $3.63M | Buy |
263,931
+18,239
| +7% | +$251K | 0.01% | 519 |
|
|
2022
Q1 | $3.9M | Sell |
245,692
-1,043,313
| -81% | -$16.5M | 0.01% | 571 |
|
|
2021
Q4 | $28.1M | Buy |
1,289,005
+79,437
| +7% | +$1.73M | 0.06% | 349 |
|
|
2021
Q3 | $36.2M | Sell |
1,209,568
-438,903
| -27% | -$13.1M | 0.09% | 329 |
|
|
2021
Q2 | $73M | Sell |
1,648,471
-3,723
| -0.2% | -$165K | 0.18% | 173 |
|
|
2021
Q1 | $73.3M | Buy |
1,652,194
+62,142
| +4% | +$2.76M | 0.19% | 177 |
|
|
2020
Q4 | $87.2M | Sell |
1,590,052
-1,343
| -0.1% | -$73.7K | 0.23% | 131 |
|
|
2020
Q3 | $36.4M | Buy |
1,591,395
+254,673
| +19% | +$5.82M | 0.12% | 271 |
|
|
2020
Q2 | $28M | Sell |
1,336,722
-176,632
| -12% | -$3.7M | 0.1% | 320 |
|
|
2020
Q1 | $21.1M | Buy |
1,513,354
+492,820
| +48% | +$6.87M | 0.09% | 314 |
|
|
2019
Q4 | $23.2M | Buy |
1,020,534
+595,821
| +140% | +$13.6M | 0.08% | 368 |
|
|
2019
Q3 | $4.95M | Sell |
424,713
-28,767
| -6% | -$335K | 0.02% | 634 |
|
|
2019
Q2 | $6.8M | Buy |
453,480
+133,119
| +42% | +$2M | 0.02% | 625 |
|
|
2019
Q1 | $5.62M | Sell |
320,361
-7,592
| -2% | -$133K | 0.02% | 642 |
|
|
2018
Q4 | $4.86M | Sell |
327,953
-84,783
| -21% | -$1.26M | 0.02% | 655 |
|
|
2018
Q3 | $10.2M | Buy |
412,736
+56,222
| +16% | +$1.38M | 0.03% | 618 |
|
|
2018
Q2 | $7M | Buy |
+356,514
| New | +$7M | 0.02% | 680 |
|